Y Lurie
Overview
Explore the profile of Y Lurie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
327
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gane E, Kershenobich D, Seguin-Devaux C, Kristian P, Aho I, Dalgard O, et al.
J Viral Hepat
. 2015 Jan;
22 Suppl 1:46-73.
PMID: 25560841
The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 15 countries, and the relative impact of two scenarios was considered: (i) increased treatment efficacy while holding the treated...
2.
Hatzakis A, Chulanov V, Gadano A, Bergin C, Ben-Ari Z, Mossong J, et al.
J Viral Hepat
. 2015 Jan;
22 Suppl 1:26-45.
PMID: 25560840
Morbidity and mortality attributable to chronic hepatitis C virus (HCV) infection are increasing in many countries as the infected population ages. Models were developed for 15 countries to quantify and...
3.
Saraswat V, Norris S, de Knegt R, Sanchez Avila J, Sonderup M, Zuckerman E, et al.
J Viral Hepat
. 2015 Jan;
22 Suppl 1:6-25.
PMID: 25560839
Chronic hepatitis C virus (HCV) infection is a leading cause of liver related morbidity and mortality. In many countries, there is a lack of comprehensive epidemiological data that are crucial...
4.
Lurie Y, Slotky M, Fischer D, Shreter R, Bentur Y
Clin Toxicol (Phila)
. 2013 Sep;
51(9):834-7.
PMID: 24032468
Context: Corrosive substance ingestion is a toxicological emergency with relatively high mortality requiring rational surgical decisions. Objective: Evaluate the role of chest and abdominal computed tomography (CT) in assessing the...
5.
Mor Z, Lurie Y, Katchman E
Int J STD AIDS
. 2012 Jul;
23(7):529-30.
PMID: 22844014
Hepatitis A virus (HAV) vaccination is recommended for men who have sex with men (MSM) and other susceptible populations, who are at increased risk for HAV infection, such as HIV-positive...
6.
Maor Y, Schapiro J, Bashari D, Lurie Y, Safadi R, Segol O, et al.
Haemophilia
. 2008 Jan;
14(2):336-42.
PMID: 18205802
Treatment with pegylated interferon (Peg-IFN) and ribavirin, now the standard of care, has been shown to achieve sustained viral response (SVR) in up to 60% of patients with hepatitis C...
7.
Rosner G, Lurie Y, Blendis L, Halpern Z, Oren R
Postgrad Med J
. 2006 Mar;
82(965):207-10.
PMID: 16517803
Background: Since the adoption of a universal hepatitis B immunisation strategy, the reported incidence of acute hepatitis B has declined dramatically worldwide including in Israel. However, new cases of acute...
8.
Schmilovitz-Weiss H, Ben-Ari Z, Sikuler E, Zuckerman E, Sbeit W, Ackerman Z, et al.
Liver Int
. 2004 Nov;
24(6):547-51.
PMID: 15566503
Background: Experience with lamivudine treatment of immunocompetent patients with acute hepatitis B is limited. Aim Of Study: To evaluate the safety and efficacy of lamivudine for the treatment of acute...
9.
Radan L, Mor M, Gips S, Schlag-Eisenberg D, Lurie Y, Dickstein K, et al.
Clin Nucl Med
. 2004 Apr;
29(4):255-61.
PMID: 15096974
Objectives: The objectives of this study were to evaluate the added clinical value of spiral computed tomographic angiography (CTA) after ventilation-perfusion lung scintigraphy (V/Q) for the management of patients with...
10.
Lurie Y, Nevens F, Aprosina Z, Fedorova T, Kalinin A, Klimova E, et al.
J Viral Hepat
. 2002 Sep;
9(5):346-53.
PMID: 12225329
Interferon- (IFN-)alpha is currently the standard of care treatment for patients with chronic hepatitis C virus (HCV) infection. A significant part of the benefit of IFN-alpha in chronic hepatitis C...